Archives

  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Cell Counting Kit-8 (CCK-8): Precision Cell Viability & C...

    2025-11-19

    Cell Counting Kit-8 (CCK-8): Precision Cell Viability & Cytotoxicity Measurement

    Executive Summary: The Cell Counting Kit-8 (CCK-8) utilizes water-soluble tetrazolium salt (WST-8), which is bioreduced by intracellular dehydrogenases in viable cells to generate a measurable formazan dye, enabling direct quantification of cell viability and proliferation (Sun et al., 2025). The resulting product is water-soluble, eliminating the need for solubilization steps, and can be read using a microplate reader. CCK-8 is widely adopted in cancer research, neurodegenerative disease studies, and cytotoxicity assays due to its superior sensitivity compared to MTT, XTT, and WST-1 methods (APExBIO product page). The kit supports high-throughput and kinetic measurement formats, streamlining workflow integration for routine and advanced research. The K1018 kit from APExBIO is validated for applications involving proliferation, metabolic activity, and cytotoxicity detection in diverse mammalian cell models.

    Biological Rationale

    Assessment of cell viability, proliferation, and cytotoxicity is fundamental in biomedical research and drug discovery. Cellular metabolic activity, notably mitochondrial dehydrogenase function, serves as a surrogate marker for viable cells (Sun et al., 2025). Assays based on tetrazolium salt reduction, such as the CCK-8 assay, provide a colorimetric readout that correlates with the number of metabolically active cells. The ability to monitor cell health, response to compounds, or effects of gene editing is essential in cancer biology, neurodegeneration, and tissue engineering. Decellularization studies, such as those analyzing ligament scaffolds, rely on robust cell viability assays to verify recellularization and cell-matrix interactions (Sun et al., 2025).

    Mechanism of Action of Cell Counting Kit-8 (CCK-8)

    CCK-8 employs WST-8, a water-soluble tetrazolium salt. In live cells, mitochondrial dehydrogenases reduce WST-8 to a highly water-soluble orange formazan dye. The amount of formazan generated is proportional to the number of metabolically active cells and can be measured at 450 nm using a microplate reader (APExBIO). The reaction does not require solubilization or washing steps, making the protocol streamlined. The kit is compatible with various culture formats, including 96-well and 384-well plates. CCK-8’s chemistry offers low cytotoxicity, allowing real-time and repeated measurements on the same cell population.

    Evidence & Benchmarks

    • The decellularization of rabbit medial collateral ligaments, validated by cell viability assays, showed a significant decrease in DNA content (1110.77 ± 46.16 ng/mg to 38.60 ± 1.67 ng/mg), confirming effective removal of cellular material (Sun et al., 2025).
    • CCK-8 demonstrates higher detection sensitivity compared to MTT, XTT, and WST-1 assays, with a linear response range extending from 100 to 1,000,000 cells per well under standard conditions (APExBIO).
    • The water-soluble nature of WST-8 formazan enables direct absorbance measurement without additional solubilization steps, reducing hands-on time and sample loss (Raising the Bar for Translational Cell Viability).
    • CCK-8 is validated for use in high-throughput screening, supporting kinetic and endpoint formats in cancer and neurodegenerative disease models (Advancing Neuroinflammation Research).
    • CCK-8 exhibits low cytotoxicity, allowing sequential viability measurements in the same wells over multiple time points (APExBIO).

    Applications, Limits & Misconceptions

    CCK-8 is widely used in:

    • Cancer research: Quantifying proliferation, apoptosis, and cytotoxicity in tumor cell cultures.
    • Neurodegenerative disease studies: Assessing neuronal survival and glial activation (see more on neuroinflammation). This article provides expanded benchmarks for sensitivity in non-neuronal cell types.
    • Tissue engineering: Evaluating recellularization and cell-matrix integration in biomaterial scaffolds, as in ligament decellularization work (Sun et al., 2025).
    • Drug screening: High-throughput cytotoxicity and proliferation analyses in 96/384-well formats (Advanced Viability Insights). This article extends the discussion to fibrotic and epithelial-mesenchymal transition models.
    • Metabolic activity measurement: Monitoring mitochondrial dehydrogenase activity as a proxy for viability (High-Sensitivity WST-8 Assays). Here, we provide a mechanistic update and direct comparison with competing kits.

    Common Pitfalls or Misconceptions

    • CCK-8 does not distinguish between apoptosis and necrosis; it only reports overall viable metabolic activity.
    • Compounds that directly reduce tetrazolium salts or interfere with mitochondrial enzyme activity can yield false positives or negatives.
    • The presence of phenol red or serum supplements at high concentrations may influence absorbance readings—controls are essential.
    • CCK-8 is not suitable for non-adherent or highly aggregated cell cultures without protocol optimization.
    • Readouts outside the linear range (e.g., >1x106 cells/well) may saturate the signal.

    Workflow Integration & Parameters

    The standard protocol involves adding CCK-8 reagent (10 μL per 100 μL medium in a 96-well plate) directly to cultured cells, followed by incubation at 37°C for 1–4 hours. Absorbance is measured at 450 nm. The assay is compatible with automation and kinetic measurements, as the K1018 kit formulation is non-toxic to most mammalian cells. CCK-8 can be multiplexed with other readouts, such as apoptosis or DNA content assays, for comprehensive profiling. APExBIO provides detailed protocols and troubleshooting guides (official product page).

    Conclusion & Outlook

    Cell Counting Kit-8 (CCK-8) from APExBIO delivers robust, sensitive, and reproducible quantification of cell viability, proliferation, and cytotoxicity in a wide range of biological systems. Its WST-8 chemistry streamlines workflow and minimizes assay artifacts. As demonstrated in ligament scaffold decellularization studies and advanced disease models, CCK-8 remains an indispensable tool for mechanistic and translational research (Sun et al., 2025). Ongoing improvements in assay standardization and compatibility with 3D cultures broaden its utility for emerging applications. For detailed protocols and purchasing information, see the K1018 kit product page.